Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid

BACKGROUND: The treatment of latent tuberculosis infection (LTBI) in individuals at risk of reactivation is essential for tuberculosis control. However, blood biomarkers associated with LTBI treatment have not been identified. METHODS: Blood samples from tuberculin skin test (TST) reactive individua...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol Res
Autors principals: de Oyarzabal, Eleane, García-García, Lourdes, Rangel-Escareño, Claudia, Ferreyra-Reyes, Leticia, Orozco, Lorena, Herrera, María Teresa, Carranza, Claudia, Sada, Eduardo, Juárez, Esmeralda, Ponce-de-León, Alfredo, Sifuentes-Osornio, José, Wilkinson, Robert J., Torres, Martha
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925913/
https://ncbi.nlm.nih.gov/pubmed/31886294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1297131
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars